Invests in
Stages:
Sectors:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Richard
Work Experience
Venture Partner
2019
Entrepreneur In Residence
2018 - 2019
Co-founder and Chief Medical Officer
2021
2014 - 2017
VP
2014 - 2017
My responsibility at Biogen as VP, and Research/Early Development Unit Head for Neuroimmunology & MS/Pain/Acute Neurology ([NIPAN]; 2014-2017) entailed leading a group of >45 scientists and clinicians in finding and prosecuting neuroinflammatory targets for treatment of neurological disease and pain, and bringing those relevant for acute neurology indications through phase II proof of concept (PoC). During this time, I led the transformation of the neuroinflammation portfolio, successfully bringing 5 compounds (internally developed and externally identified) into the clinic as well as directing activities in blood-brain barrier (BBB) function, progressive multifocal leukoencephalopathy (PML) risk mitigation and novel screening technologies for glial targets, in addition to basic neuroinflammation biology.
1989 - 2014
Member Of Scientific Staff
1989 - 2014
1984 - 2014
Neurologist
1984 - 2014
Staff Neurologist, Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic. Named in "Best Doctors" 1996-2014"